HR-4983 : Still Just a Bill


This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Action Timeline

Action DateTypeTextSource
2016-04-27CommitteeReferred to the Subcommittee on Indian, Insular and Alaska Native Affairs.House committee actions
2016-04-22CommitteeReferred to the Subcommittee on Health.House committee actions
2016-04-18IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2016-04-18IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2016-04-18IntroReferralIntroduced in HouseLibrary of Congress

Sponsor :

H. Morgan Griffith [R] (VA-9)
See Cosponsors

Policy Area :

Health
Related Subjects
  • Drug, alcohol, tobacco use
  • Drug trafficking and controlled substances
  • Health information and medical records
  • Health promotion and preventive care
  • Indian social and development programs
  • Minority health
  • Prescription drugs
Related Geographic Entities
Related Organizations

Related Bills

See Related Bills